Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
CDMO France is the industry association website for French contract pharmaceutical manufacturing companies. It brings together major French, European, and global pharmaceutical subcontractors with manufacturing sites in France. The crawled content indicates that the association covers around 80 industrial sites in France and 18,000 employees in the country, while also showcasing members, production capabilities, and industry news. As such, it is closer to an “industry association website + CDMO supplier directory” than a typical SaaS or enterprise software product.
The site’s clearest function is searching pharmaceutical manufacturing capabilities. Users can filter French pharmaceutical subcontractors by dosage form, including solid forms, liquid forms, semi-solid forms, sterile liquids, as well as other formats such as diagnostic tests, patches, aerosols, respiratory products, pilot-batch packaging, and more. The pages also list member companies and the number of dosage-form categories they cover, such as Delpharm, Cenexi, and Benta Lyon. The news section provides analysis on supply-chain risks, geopolitics, energy costs, and logistics costs and how they affect pharmaceutical manufacturing prices.
The crawled text does not provide any plans, subscription pricing, free trials, payment methods, or commercial software licensing information. It also does not show account systems, team collaboration, permission management, third-party integrations, APIs, developer documentation, data security certifications, or cloud/self-hosted deployment options. Therefore, by SaaS standards, its disclosed digital capabilities are limited, and it should not be regarded as a full-fledged enterprise software product.
Its strengths are its vertical focus and concentration on the French CDMO ecosystem, helping pharmaceutical companies quickly understand local outsourced drug manufacturing resources in France. The dosage-form-based filtering structure is practically useful for initial supplier screening. Its limitations are that the functionality remains at the directory and content-display level: there is no visible quotation workflow, project collaboration, supplier rating, compliance document management, or online transaction process. In addition, the content is mainly in French, which creates a language barrier for Chinese users.
It is suitable for pharmaceutical companies looking for CDMO resources in France, BD/procurement teams, supply-chain researchers, and organizations interested in the resilience of European pharmaceutical manufacturing. Access from China is not covered in the text, and network connectivity, payment, and registration processes are all unknown. If a more international supplier database is needed, platforms such as Pharmasource, PharmaCompass, Contract Pharma Directory, and CPhI Online may be worth comparing.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on cdmo-france.com official site.
cdmo-france.com is an France Organizations provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach cdmo-france.com directly.